PDCD1/PD1/CD279 (Sintilimab biosimilar) Antibody from ABBEXA LTD

Search, find, compare suppliers for anti-PDCD1/PD1/CD279 (Sintilimab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityPDCD1/PD1/CD279 (Sintilimab biosimilar)
Clonemonoclonal
Host SpeciesRecombinant Human
Reactive Specieshuman
IsotypeIgG4 kappa
FormatProtein A/G purified
Size100 µg, 1 mg,
Concentrationtypically between 0.5-2.0 mg/ml.
ApplicationsELISA, WB
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSintilimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting PDCD1/PD1/CD279, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Sintilimab is a fully human anti-PD-1 antibody for tumor immunotherapy. It adopts IgG4 molecular framework and modified its hinge region sequence (S228P). Sintilimab, as a programmed death receptor 1 (PD-1) blocker, can bind to PD-1 molecules on the surface of T cells and relieve the inhibitory effect of PD-1 pathway on T cells.
Immunogenn/a
Other NamesSintilimab, PDCD1/PD1/CD279, 2072873-06-2
Gene, Accession #CAS: 2072873-06-2
Catalog #abx831496
Priceplease inquire
Order / More InfoPDCD1/PD1/CD279 (Sintilimab biosimilar) Antibody from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.